Announcements Trials
Browse Landscape

Phase

Phase NA 14Phase 3 10Phase 2 10Phase 1 4Phase EARLY_PHASE1 1Phase 4 1Phase 2/3 1

Status

Completed 7Terminated 4Recruiting 4Active not recruiting 3Withdrawn 1Not yet recruiting 1

Sponsor Class

OTHER 3INDUSTRY 1

Study Type

Interventional 4

Sponsor

Cancer Type

Tumor-Agnostic 1Other hematologic neoplasm 1CNS 1

Conditions

Smoking Cessation 1Neoplasms 1Hematologic Neoplasms 1Glioma 1

Interventions

Cyclophosphamide 98pembrolizumab 85Gemcitabine 81Carboplatin 62fludarabine 61Nivolumab 57Cisplatin 54Paclitaxel 51Radiotherapy 50Docetaxel 49Rituximab 46Dexamethasone 42Lenalidomide 41Ipilimumab 38Azacitidine 35Etoposide 34Cytarabine 33Temozolomide 32Bevacizumab 32Radiation 29venetoclax 28Bortezomib 27Magnetic Resonance Spectroscopy 26Irinotecan 26Pemetrexed 25atezolizumab 24Oxaliplatin 24Capecitabine 24fludarabine phosphate 22Filgrastim 22

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Phase 1 × Terminated × Standard of Care × Clear all
NCT04060849 2024-11-08

Nozin in Preventing Respiratory Viral Infections in Patients Undergoing Stem Cell Transplant, PREV-NOSE STUDY

Fred Hutchinson Cancer Center

Phase 1 Terminated
10 enrolled
Other hematologic neoplasm

Hematologic Neoplasms

NCT01479998 2020-03-09

Novel Treatments to Enhance Smoking Cessation Before Cancer Surgery: Effects on Smoking and Surgical Outcomes

Yale University

Phase 1 Terminated
8 enrolled

Smoking Cessation

NCT02371031 2016-11-30

FDOPA-PET/MRI for the Pre-operative Evaluation of Gliomas

Washington University School of Medicine

Phase 1 Terminated
11 enrolled
CNS

Glioma

NCT01558687 2014-02-04

Cilengitide Imaging Trial in Glioblastoma

Merck KGaA, Darmstadt, Germany

Phase 1 Terminated
1 enrolled
Tumor-Agnostic

Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡